Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agre...
Singapore: US-based medical device manufacturer Cook Medical is again shipping its Zilver PTX Drug-Eluting Peripheral St...
Singapore: The Japanese Ministry for Health and Welfare has recently given its nod for Novatris' Cosentyx, that treats p...
Singapore: Halaven (Eribulin), indicated for the treatment of advanced or metastatic breast cancer, developed by Japanes...
Singapore: Pronova BioPharma and Takeda's Lotriga granular capsule 2g is now available for the treatment of hyperlipide...
Singapore: Takeda Pharmaceutical has partnered with Chemo-Sero-Therapeutic Research Institute for the distribution of Ka...
Singapore: The board of directors of Japanese pharmaceutical giant Daiichi Sankyo Company Limited approved a resolution ...
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...
Singapore: Japanese researchers claim that they have developed a new device that can detect cancer from a drop of blood ...
Tokyo's Mochida Pharmaceutical Co. Ltd. has filed for a new drug application (NDA) for MD-0901 with the Japanese Ministr...
Singapore: Assuming the role of Prime Minister of Japan in December 2012, Mr Shinzo Abe has provided a boon for Japanese...
The seventeenth edition of BioJapan 2015, one of Asia's largest partnering events, will be held for three days from Octo...
Singapore: Bayer's Eylea (aflibercept) injection for myopic choroidal neovascularization (myopic CNV) has received an ap...
Singapore: Revealing that one out of 27 babies born in Japan in 2012 were through test-tube fertilization, Japan's Assoc...
Singapore: Astellas pharma recently announced collaboration with Immunomic Therapeutics to develop and commercialize JRC...
Singapore: Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 worldwide due to the pate...
Singapore: Astellas Pharma and UMN Pharma have highlighted that the summary results for phase III clinical trial showed...
Singapore: Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Novartis' Cosentyx (secukinumab, formerly...
